Aktas, B and colleges evaluated the expression of EMT and stem cell markers in CTCs isolated from patients with breast cancer during follow-up and detected EMT marker and ALDH1 expression in only 10% and 5% of responders, respectively, whereas these percentages were much higher in non-responders (62% and 44%, respectively) [103]. The gene discussed is ALDH1A1; the disease is breast cancer.